- Home
- AUB vs MRUS Comparison
AUB vs MRUS Comparison
Compare AUB & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUB
- MRUS
- Stock Information
- Founded
- AUB 1902
- MRUS 2003
- Country
- AUB United States
- MRUS Netherlands
- Employees
- AUB N/A
- MRUS N/A
- Industry
- AUB Major Banks
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- AUB Finance
- MRUS Health Care
- Exchange
- AUB Nasdaq
- MRUS Nasdaq
- Market Cap
- AUB 3.5B
- MRUS 2.7B
- IPO Year
- AUB N/A
- MRUS 2016
- Fundamental
- Price
- AUB $29.40
- MRUS $42.77
- Analyst Decision
- AUB Buy
- MRUS Strong Buy
- Analyst Count
- AUB 5
- MRUS 14
- Target Price
- AUB $39.00
- MRUS $87.00
- AVG Volume (30 Days)
- AUB 1.9M
- MRUS 786.0K
- Earning Date
- AUB 04-24-2025
- MRUS 05-07-2025
- Dividend Yield
- AUB 4.61%
- MRUS N/A
- EPS Growth
- AUB N/A
- MRUS N/A
- EPS
- AUB 2.15
- MRUS N/A
- Revenue
- AUB $797,879,000.00
- MRUS $54,732,000.00
- Revenue This Year
- AUB $78.93
- MRUS $26.81
- Revenue Next Year
- AUB $15.95
- MRUS $23.85
- P/E Ratio
- AUB $13.71
- MRUS N/A
- Revenue Growth
- AUB 16.62
- MRUS N/A
- 52 Week Low
- AUB $22.85
- MRUS $33.19
- 52 Week High
- AUB $44.54
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- AUB 59.18
- MRUS 49.60
- Support Level
- AUB $28.42
- MRUS $37.92
- Resistance Level
- AUB $29.64
- MRUS $46.36
- Average True Range (ATR)
- AUB 0.87
- MRUS 2.56
- MACD
- AUB 0.59
- MRUS -0.22
- Stochastic Oscillator
- AUB 95.74
- MRUS 57.46
About AUB Atlantic Union Bankshares Corporation
Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.